Growth Metrics

Baxter International (BAX) Capital Expenditures (2016 - 2025)

Baxter International (BAX) has disclosed Capital Expenditures for 17 consecutive years, with $140.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 6.06% to $140.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $513.0 million, a 15.02% increase, with the full-year FY2025 number at $513.0 million, up 15.02% from a year prior.
  • Capital Expenditures was $140.0 million for Q4 2025 at Baxter International, up from $111.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $183.0 million in Q4 2021 to a low of -$61.0 million in Q4 2022.
  • A 5-year average of $123.0 million and a median of $138.5 million in 2022 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: plummeted 133.33% in 2022, then soared 1016.67% in 2024.
  • Baxter International's Capital Expenditures stood at $183.0 million in 2021, then plummeted by 133.33% to -$61.0 million in 2022, then skyrocketed by 250.82% to $92.0 million in 2023, then soared by 43.48% to $132.0 million in 2024, then rose by 6.06% to $140.0 million in 2025.
  • Per Business Quant, the three most recent readings for BAX's Capital Expenditures are $140.0 million (Q4 2025), $111.0 million (Q3 2025), and $140.0 million (Q2 2025).